Tris[2-chloro-1-(chloromethyl)ethyl] phosphate

CAS13674-87-8
EC237-159-2

List details

Basic info

Status Withdrawn
Details on the scope of restriction Restricting the placing on the market of childcare articles and residential upholstered furniture with PUR foams containing TCEP, TCPP and TDCP. A restriction may cover mattresses for adults and textiles as well.
Reason for restriction ECHA’s screening assessment identified a risk for children from exposure to the flame retardants TCEP, TCPP and TDCP in flexible polyurethane (PUR) foams in childcare articles and residential upholstered furniture. The Commission requested ECHA to prepare a restriction proposal.

Intention timeline

Date of intention 2018-06-06
Expected date of submission 2019-07-19
Withdrawal date 2019-07-19
Latest update 2019-07-17

Support information

Reason for withdrawal Pending the availability of new critical data (US NTP studies on the carcinogenicity of TCPP) that will not be available within the originally foreseen 12 month timeline, the Dossier Submitter (ECHA) is unable to complete the Annex XV dossier. Therefore, the Dossier Submitter withdraws the entry in the RoI until further information on the availability of the study results becomes available.

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
April 9, 2021
  • Name: tris[2-chloro-1-(chloromethyl)ethyl] phosphateTris[2-chloro-1-(chloromethyl)ethyl] phosphate
March 31, 2021
  • Name: Tris[2-chloro-1-(chloromethyl)ethyl] phosphatetris[2-chloro-1-(chloromethyl)ethyl] phosphate
July 17, 2019
  • Latest update: 2019-04-032019-07-17
  • Remarks: Stakeholders are requested to provide any information relevant to the Dossier Submitter during the Annex XV Restriction Dossier process, either in any call for evidence or separately during the process. This information will be used, amongst other issues, to determine if any derogations are required for the potential restriction as these cannot be proposed without adequate risk and socio-economic information. If a derogation is not proposed by the Dossier Submitter then it will be incumbent on the relevant stakeholders to do so during any public consultation process with a full risk and socio-economic justification accompanying it.
  • Status: IntentionWithdrawn
  • Reason for withdrawal: Pending the availability of new critical data (US NTP studies on the carcinogenicity of TCPP) that will not be available within the originally foreseen 12 month timeline, the Dossier Submitter (ECHA) is unable to complete the Annex XV dossier. Therefore, the Dossier Submitter withdraws the entry in the RoI until further information on the availability of the study results becomes available.
  • Withdrawal date: 2019-07-19
April 4, 2019
  • Expected date of submission: 2019-04-122019-07-19
  • Latest update: 2018-12-212019-04-03
Feb. 18, 2019
  • Latest update: 2019-02-072018-12-21
Feb. 8, 2019
  • Latest update: 2018-12-212019-02-07
  • Submitter: ECHA
Jan. 3, 2019
  • Latest update: 2018-08-162018-12-21
Add the related substance to your watchlist to monitor this regulatory record.